Symbol="GANX"
AssetType="Common Stock"
Name="Gain Therapeutics Inc"
Description="Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is headquartered in Bethesda, Maryland."
CIK="1819411"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="44753500"
EBITDA="-22203662"
PERatio="None"
PEGRatio="None"
BookValue="0.878"
DividendPerShare="0"
DividendYield="0"
EPS="-1.57"
RevenuePerShareTTM="0.005"
ProfitMargin="0"
OperatingMarginTTM="-403.64"
ReturnOnAssetsTTM="-0.555"
ReturnOnEquityTTM="-1.158"
RevenueTTM="55180"
GrossProfitTTM="-7660886"
DilutedEPSTTM="-1.57"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.47"
AnalystTargetPrice="9"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="210.97"
PriceToBookRatio="1.636"
EVToRevenue="85.18"
EVToEBITDA="-0.954"
Beta="0.326"
num_52WeekHigh="6.19"
num_52WeekLow="2.8"
num_50DayMovingAverage="4.29"
num_200DayMovingAverage="4.124"
SharesOutstanding="12328800"
DividendDate="None"
ExDividendDate="None"
symbol="GANX"
open="3.65"
high="3.65"
low="3.45"
price="3.58"
volume="45192.00"
latest_trading_day="2023-08-21"
previous_close="3.63"
change="-0.05"
change_percent="-1.3774%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="41"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="58556"
Change_recent_avg="-0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_negative_thumbnail_id_2="1131"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="960"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
